Emerging role of cathepsin S in obesity and its associated diseases
- 1 January 2007
- journal article
- review article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 45 (3) , 328-32
Abstract
Obesity is thought to be a major determinant in the development of cardiovascular diseases, but the mechanisms whereby enlarged adipose tissue affects vascular function remain poorly defined. Chronic inflammation is a common feature of obesity and atherosclerosis, and several inflammatory markers produced by adipose tissue have been considered as candidates that potentially favor the development of atherosclerotic lesions in humans. To identify other effective candidates, we combined bioclinical data for individuals of increasing weight with adipose tissue gene-expression profiling. This strategy led to the discovery of cathepsin S (CTSS), for which gene expression was strongly correlated with subjects' body mass index (BMI). CTSS is an elastolytic cysteine protease that has been implicated in the development of atherosclerotic lesions in both animal models and humans. In this review, we discuss the role of CTSS in obesity and atherosclerosis, and emphasize the potential mechanisms that could link the two diseases. We also position this protease as a potential therapeutic target to reduce associated cardiovascular risks in obese patients.Keywords
This publication has 45 references indexed in Scilit:
- Increased serum cathepsin S in patients with atherosclerosis and diabetesAtherosclerosis, 2006
- Macrophage-secreted factors induce adipocyte inflammation and insulin resistanceBiochemical and Biophysical Research Communications, 2006
- Localization of Cysteine Protease, Cathepsin S, to the Surface of Vascular Smooth Muscle Cells by Association with Integrin ανβ3The American Journal of Pathology, 2006
- Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesisThe FASEB Journal, 2005
- Human Epicardial Adipose Tissue Is a Source of Inflammatory MediatorsCirculation, 2003
- Differential Expression of Cysteine and Aspartic Proteases during Progression of Atherosclerosis in Apolipoprotein E-Deficient MiceThe American Journal of Pathology, 2002
- Essential Role for Cathepsin S in MHC Class II–Associated Invariant Chain Processing and Peptide LoadingImmunity, 1996
- Expression of Rat Cathepsin S in Phagocytic CellsJournal of Biological Chemistry, 1996
- The cystatins: Protein inhibitors of cysteine proteinasesFEBS Letters, 1991
- Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors.Journal of Clinical Investigation, 1984